从动态对比增强MRI进行药理学参数估计的未配对深度学习,没有AIF测量
Gyutaek Oh1, Yeonsil Moon2, Won-Jin Moon3
1Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), 291, Daehak-ro, Yuseong-gu, 34141, Daejeon, Republic of Korea.
这项研究引入了一种用于动态对比增强MRI (DCE-MRI) 的新型深度学习方法,以准确估计药理动力学参数,而不需要标记数据或单独的动脉输入功能 (AIF) 测量.
科学领域:
- 医疗成像医学成像
- 生物物理学的生物物理.
- 机器学习 机器学习
背景情况:
- 动态对比增强型MRI (DCE-MRI) 使用药理学参数量化组织输液和血管透性.
- 传统的DCE-MRI运动建模是计算密集的,对杂的动脉输入函数 (AIF) 数据敏感.
- 现有的深度学习方法通常需要监督式学习,配对DCE-MRI和标记的参数图,这些资源密集型,容易标记噪音.
研究的目的:
- 开发一种无监督的深度学习方法,用于准确的DCE-MRI药理动力学参数估计.
- 克服监督学习的局限性,包括数据要求和标签噪声.
- 消除在DCE-MRI分析中需要单独的AIF测量.
主要方法:
- 开发了一个基于物理的CycleGAN框架,用于未配对的深度学习.
- 循环GAN架构具有简化的设计,只有一个生成器和区分器对.
- 该方法将物理原理集成到深度学习模型中,以进行可靠的参数估计.
主要成果:
- 拟议的方法成功地估计了药理动力学参数,而不需要标记的DCE-MRI数据.
- 这种方法不需要单独测量动脉输入功能 (AIF).
- 实验结果表明,与现有技术相比,药物动力学参数估计的可靠性更高.
结论:
- 物理驱动的未配对深度学习方法为DCE-MRI分析提供了实用解决方案.
- 这种方法减少了计算复杂性,并提高了药理动力学参数估计的准确性.
- 消除AIF测量简化了工作流程,并提高了DCE-MRI的适用性.
更多相关视频
11:28Concurrent EEG and Functional MRI Recording and Integration Analysis for Dynamic Cortical Activity Imaging
Published on: June 30, 2018
10:21Continuous Blood Sampling in Small Animal Positron Emission Tomography/Computed Tomography Enables the Measurement of the Arterial Input Function
Published on: August 8, 2019
相关概念视频
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's overall...
Estimation of k and VD of Aminoglycosides
